You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

Details for Patent: 11,717,571


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,717,571 protect, and when does it expire?

Patent 11,717,571 protects NEFFY and is included in one NDA.

This patent has seventy patent family members in twenty-eight countries.


Drugs Protected by US Patent 11,717,571

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ars Pharms Operation NEFFY epinephrine SPRAY;NASAL 214697-001 Aug 9, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up NASAL ADMINISTRATION OF EPINEPHRINE FOR THE TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,717,571

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2009329952 ⤷  Sign Up
Australia 2011317202 ⤷  Sign Up
Australia 2019217643 ⤷  Sign Up
Australia 2021254650 ⤷  Sign Up
Australia 2024201523 ⤷  Sign Up
Brazil 112020015646 ⤷  Sign Up
Brazil PI0923403 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.